Published in Int J Cancer on April 15, 1975
Distribution of a major connective tissue protein, fibronectin, in normal human tissues. J Exp Med (1978) 3.95
Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res (1997) 2.98
Intranuclear localization of snRNP antigens. J Cell Biol (1986) 2.54
Expression of intermediate filaments in cultured cells. J Cell Sci (1981) 2.25
Sequential appearance of fibronectin and collagen in experimental granulation tissue. Lab Invest (1980) 2.16
Nonsense suppressors of Saccharomyces cerevisiae can be generated by mutation of the tyrosine tRNA anticodon. Nature (1976) 2.07
Biosynthesis of the beta and beta' subunits of RNA polymerase in Escherichia coli. J Mol Biol (1973) 2.03
Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia. Int J Cancer (1976) 1.97
Replication of the F'lac sex factor in the cell cycle of Escherichia coli. Mol Gen Genet (1971) 1.92
Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody. Biochemistry (1982) 1.85
Cytochemical characterization of deoxyribonucleoprotein in individual cell nuclei. Techniques for obtaining heat denaturation curves with the aid of acridine orange microfluorimetry and ultraviolet microspectrophotometry. Exp Cell Res (1969) 1.82
Human smooth muscle autoantibodies reacting with intermediate (100 A) filaments. Nature (1977) 1.82
Somatic mutation of the Peutz-Jeghers syndrome gene, LKB1/STK11, in malignant melanoma. Oncogene (1999) 1.59
The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis. Cancer Res (1996) 1.55
Hybridization of a myeloid leukemia-derived human cell line (K562) with a human Burkitt's lymphoma line (P3HR-1). J Natl Cancer Inst (1980) 1.53
High frequency of silent inflammatory bowel disease in spondylarthropathy. Arthritis Rheum (1994) 1.50
Distribution of fibronectin in human tissues and relationship to other connective tissue components. Ann N Y Acad Sci (1978) 1.47
Inducibility of the Epstein-Barr virus (EBV) cycle and surface marker properties of EBV-negative lymphoma lines and their in vitro EBV-converted sublines. Int J Cancer (1976) 1.41
Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity. Blood (1998) 1.41
Changes in the cytochemical properties of erythrocyte nuclei reactivated by cell fusion. J Cell Sci (1969) 1.39
Higher-order structure of human mitotic chromosomes. Proc Natl Acad Sci U S A (1977) 1.38
Isolation of novel HLA-DR restricted potential tumor-associated antigens from the melanoma cell line FM3. Cancer Res (1997) 1.38
[Why should we defend the Scandinavian languages?]. Nord Med (1993) 1.37
Identification of an Epstein-Barr virus-coded thymidine kinase. EMBO J (1986) 1.31
Activation of complement by cytoskeletal intermediate filaments. Nature (1979) 1.30
Fluorescent antibodies and lectins stain intracellular structures in fixed cells treated with nonionic detergent. J Histochem Cytochem (1978) 1.30
Glial fibrillary acidic protein and intermediate filaments in human glioma cells. Acta Neuropathol (1979) 1.29
Changes in expression of fibroblast surface antigen (SFA) during cytodifferentiation and heterokaryon formation. Differentiation (1976) 1.29
Alterations of the MMAC1/PTEN gene in lymphoid malignancies. Blood (1998) 1.27
Accumulation of identical T cells in melanoma and vitiligo-like leukoderma. J Invest Dermatol (1999) 1.24
Preparation of microcells by enucleation of micronucleate cells. Exp Cell Res (1974) 1.20
Characterization of a human ovarian teratocarcinoma-derived cell line. Int J Cancer (1980) 1.19
Phosphorylated peptides can be transported by TAP molecules, presented by class I MHC molecules, and recognized by phosphopeptide-specific CTL. J Immunol (1999) 1.19
Changes in the distribution of a major fibroblast protein, fibronectin, during mitosis and interphase. J Cell Biol (1977) 1.18
Expression of a neural type of intermediate filament as a distinguishing feature between oat cell carcinoma and other lung cancers. Am J Pathol (1983) 1.16
Plasminogen and tissue-type plasminogen activator bind to immobilized fibronectin. J Biol Chem (1985) 1.15
Changes in deoxyribonucleoprotein during spermiogenesis in the bull. Sensitivity of DNA to heat denaturation. Exp Cell Res (1970) 1.15
Density-dependent arrest of DNA replication is accompanied by decreased levels of c-myc mRNA in myogenic but not in differentiation-defective myoblasts. J Cell Physiol (1985) 1.15
Tumour-specific MHC-class-II-restricted responses after in vitro sensitization to synthetic peptides corresponding to gp100 and Annexin II eluted from melanoma cells. Cancer Immunol Immunother (1998) 1.15
Colocalization of nestin and vimentin/desmin in skeletal muscle cells demonstrated by three-dimensional fluorescence digital imaging microscopy. Exp Cell Res (1994) 1.14
Spontaneous human squamous cell carcinomas are killed by a human cytotoxic T lymphocyte clone recognizing a wild-type p53-derived peptide. Proc Natl Acad Sci U S A (1996) 1.14
Live probiotic Bifidobacterium lactis bacteria inhibit the toxic effects induced by wheat gliadin in epithelial cell culture. Clin Exp Immunol (2008) 1.13
Mutation and allelic loss of the PTEN/MMAC1 gene in primary and metastatic melanoma biopsies. J Invest Dermatol (2000) 1.12
Characterization of human smooth muscle autoantibodies reacting with cytoplasmic intermediate filaments. Clin Immunol Immunopathol (1978) 1.10
Single-step DGGE-based mutation scanning of the p53 gene: application to genetic diagnosis of colorectal cancer. Hum Mutat (1997) 1.09
Transformation induced by Epstein-Barr virus and the role of the nuclear antigen. Cold Spring Harb Symp Quant Biol (1980) 1.08
Changes in deoxyribonucleo-protein during spermiogenesis in the bull. 3 H-Actinomycin D binding capacity. Exp Cell Res (1969) 1.08
Characterization of minicells (nuclei) obtained by cytochalasin enucleation. Exp Cell Res (1974) 1.07
Fibronectin in synovial fluid and tissue in rheumatoid arthritis. Eur J Clin Invest (1981) 1.07
Localization of DNA-dependent RNA polymerase activities in fixed human fibroblasts by autoradiography. Exp Cell Res (1973) 1.07
HLA antigen expression at the single cell level on a K562 X B cell hybrid: an analysis with monoclonal antibodies using bacterial binding assays. Somatic Cell Genet (1982) 1.06
Relation between serum group II pepsinogen concentration and the degree of Brunner's gland hyperplasia in patients with chronic renal failure. Gut (1985) 1.05
Localization of amyloid-related serum protein SAA-like material to intermediate (10 nm) filaments of cultured human embryonal fibroblasts. J Exp Med (1977) 1.05
Presentation of cytosolic glycosylated peptides by human class I major histocompatibility complex molecules in vivo. J Exp Med (1999) 1.05
Inactive proenzyme to tissue-type plasminogen activator from human melanoma cells, identified after affinity purification with a monoclonal antibody. EMBO J (1984) 1.03
Fibronectin in human solid tumors. Int J Cancer (1981) 1.03
Actinomycin binding of normal and phytohaemagglutinin stimulated lymphocytes. Exp Cell Res (1969) 1.03
Fibronectin and atherosclerosis. Acta Med Scand Suppl (1980) 1.02
Ecto-ATP diphosphohydrolase/CD39 is overexpressed in differentiated human melanomas. FEBS Lett (1998) 1.01
In situ T cells in melanoma. Cancer Immunol Immunother (1999) 1.01
Two-site time-resolved immunofluorometric assay of human insulin. Clin Chem (1986) 1.01
Direct evidence for the non-random localization of mammalian chromosomes in the interphase nucleus. Exp Cell Res (1986) 1.01
Actinomycin binding capacity of deoxyribonucleoprotein. Biochim Biophys Acta (1969) 1.00
Retinoic acid-induced differentiation of F9 embryonal carcinoma cells. Exp Cell Res (1981) 1.00
Poor correspondence between predicted and experimental binding of peptides to class I MHC molecules. Tissue Antigens (2000) 1.00
Monoclonal antibody to human 66,000 molecular weight plasminogen activator from melanoma cells. Specific enzyme inhibition and one-step affinity purification. EMBO J (1983) 0.99
Cadmium induces transcription of proto-oncogenes c-jun and c-myc in rat L6 myoblasts. J Biol Chem (1990) 0.98
Expression of basic fibroblast growth factor and vascular endothelial growth factor in primary and metastatic melanoma from the same patients. Melanoma Res (1999) 0.98
Detection of human and chick nuclear antigens in nuclei of chick erythrocytes during reactivation in heterokaryons with HeLa cells. Proc Natl Acad Sci U S A (1971) 0.98
Changes in deoxyribonucleoprotein during spermiogenesis in the bull. Exp Cell Res (1966) 0.97
Detection and characterization of alpha-beta-T-cell clonality by denaturing gradient gel electrophoresis (DGGE). Biotechniques (1998) 0.97
Monoclonal antibody that specifically inhibits a human Mr 52,000 plasminogen-activating enzyme. Proc Natl Acad Sci U S A (1982) 0.97
Nucleo-cytoplasmic protein migration during the activation of chick erythrocyte nuclei in heterokaryons. Exp Cell Res (1973) 0.96
Actinomycin binding properties of stimulated human lymphocytes. Exp Cell Res (1969) 0.96
In situ T cell responses against melanoma comprise high numbers of locally expanded T cell clonotypes. J Immunol (1999) 0.96
Enzyme-linked immunosorbent assay for human urokinase-type plasminogen activator and its proenzyme using a combination of monoclonal and polyclonal antibodies. J Immunoassay (1986) 0.96
Multiple mechanisms of immune evasion can coexist in melanoma tumor cell lines derived from the same patient. Cancer Immunol Immunother (2001) 0.96
Somatic cell hybrids between human lymphoma lines. III. Surface markers. Int J Cancer (1977) 0.96
Monoclonal antibodies to K88ab, K88ac and K88ad fimbriae from enterotoxigenic Escherichia coli. Microb Pathog (1986) 0.95
The V410I (G1228A) variant of the caspase-10 gene is a common polymorphism of the Danish population. Blood (2000) 0.95
Human-human hybridomas and human monoclonal antibodies obtained by fusion of lymph node lymphocytes from breast cancer patients. Cancer Res (1988) 0.95
Cytoskeleton antibodies in chronic active hepatitis, primary biliary cirrhosis, and alcoholic liver disease. Hepatology (1983) 0.94
Predisposition to essential hypertension and development of diabetic nephropathy in IDDM patients. Diabetes (1998) 0.94
Clonal T cell responses in tumor infiltrating lymphocytes from both regressive and progressive regions of primary human malignant melanoma. J Clin Invest (1996) 0.94
Recombinant platelet-derived growth factor-BB stimulates growth and inhibits differentiation of rat L6 myoblasts. J Biol Chem (1991) 0.94
Ro/SS-A and La/SS-B antibody level variation in patients with Sjögren's syndrome and systemic lupus erythematosus. J Autoimmun (1998) 0.93
Changes in the matrix proteins, fibronectin and collagen, during differentiation of mouse tooth germ. Dev Biol (1979) 0.92
Cell cycle arrest by the PTEN tumor suppressor is target cell specific and may require protein phosphatase activity. Exp Cell Res (2000) 0.92
Identification of antigenic regions of the human Ro 60 kDa protein using recombinant antigen and synthetic peptides. J Autoimmun (1992) 0.92
Activation of preexisting T cell clones by targeted interleukin 2 therapy. Proc Natl Acad Sci U S A (1998) 0.92
Regulation of B lymphocyte replication and maturation. J Cell Biochem (1982) 0.92
Phenotypic expression in cybrids derived from teratocarcinoma cells fused with myoblast cytoplasms. Exp Cell Res (1979) 0.91
Biochemical analysis of reactivated chick erythrocyte nuclei isolated from chick-HeLa heterokaryons. J Mol Biol (1974) 0.91
N-myc and c-src genes are differentially regulated in PCC7 embryonal carcinoma cells undergoing neuronal differentiation. J Cell Physiol (1986) 0.91
Enhancement of radiation effects by alpha interferon in the treatment of small cell carcinoma of the lung. Int J Radiat Oncol Biol Phys (1987) 0.91
Somatic cell hybrids between human lymphoma lines. IV. Establishment and characterization of a P3HR-1/Daudi hybrid. Int J Cancer (1978) 0.91
Pattern of replication of a colicin factor during the cell cycle of Escherichia coli. J Bacteriol (1972) 0.91
Aberrant p27Kip1 promoter methylation in malignant melanoma. Oncogene (2000) 0.91
IgM and IgG subclass distribution of human anti-Ro/SSA 60 kDa autoantibodies. Scand J Immunol (1994) 0.90
Reactivation of chicken erythrocyte nuclei in heterokaryons results in expression of adult chicken globin genes. Proc Natl Acad Sci U S A (1981) 0.90